Last reviewed · How we verify
Isoflavone supplement
At a glance
| Generic name | Isoflavone supplement |
|---|---|
| Sponsor | Beth Israel Deaconess Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Soy Tomato Juice to Improve Outcomes in Pancreatitis (PHASE1, PHASE2)
- Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study (PHASE2)
- Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women (NA)
- The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients (NA)
- Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment (PHASE2)
- Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression (NA)
- Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women (NA)
- A Nutritional Supplement on Vasomotor Symptoms in Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isoflavone supplement CI brief — competitive landscape report
- Isoflavone supplement updates RSS · CI watch RSS
- Beth Israel Deaconess Medical Center portfolio CI